MDL | MFCD11973642 |
---|---|
Molecular Weight | 407.45 |
Molecular Formula | C17H24F3N3O3S |
SMILES | FC(F)(F)C1=CN=C(NC([C@H]2CC[C@H](NS(=O)(C(C)(C)C)=O)CC2)=O)C=C1 |
Velneperit (S-2367) is a novel neuropeptide Y (NPY) Y5 receptor antagonist. Target: neuropeptide Y receptor Velneperit (S-2367) is a once-daily, oral, centrally acting, small molecule neuropeptide Y (NPY) Y5 receptor antagonist.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT00748605 | Shionogi|Shionogi Inc. |
Obesity
|
June 2007 | Phase 2 |
NCT00788528 | Shionogi|Shionogi Inc. |
Obesity
|
August 2008 | Phase 2 |
NCT00747929 | Shionogi|Shionogi Inc. |
Obesity
|
June 2007 | Phase 2 |
NCT01126970 | Shionogi|Shionogi Inc. |
Obesity
|
April 2010 | Phase 2 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : ≥ 30 mg/mL ( 73.63 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.4543 mL | 12.2714 mL | 24.5429 mL |
5 mM | 0.4909 mL | 2.4543 mL | 4.9086 mL |
10 mM | 0.2454 mL | 1.2271 mL | 2.4543 mL |